Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
DACT3 antisense RNA 1 | 0.931 | 0.115 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | |||||||||
|
myelodysplastic syndrome 2 translocation associated | 0.861 | 0.115 | 0.38 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
ACOXL antisense RNA 1 | 0.861 | 0.154 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2014 | 2017 | |||||||||
|
calcium and integrin binding family member 3 | 0.839 | 0.154 | 2.3E-09 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
family with sequence similarity 126 member B | 0.890 | 0.154 | 0.18 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
chromosome 11 open reading frame 21 | 0.821 | 0.192 | 1.6E-02 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2017 | ||||||||
|
leucine rich repeat containing 34 | 0.821 | 0.269 | 5.5E-07 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
elongation factor for RNA polymerase II 2 | 0.722 | 0.269 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
interaction protein for cytohesin exchange factors 1 | 0.821 | 0.269 | 1.6E-03 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
cysteine and serine rich nuclear protein 1 | 0.805 | 0.269 | 0.34 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
dystrobrevin beta | 0.805 | 0.308 | 2.8E-10 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
ras homolog family member U | 0.743 | 0.308 | 7.8E-02 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
GRAM domain containing 1B | 0.736 | 0.385 | 1.00 |
|
disease | 0.100 | None | 1.000 | 7 | 4 | 2008 | 2017 | ||||||||
|
G protein-coupled receptor 37 | 0.716 | 0.385 | 3.4E-04 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
non-SMC condensin II complex subunit H2 | 0.805 | 0.385 | 2.9E-04 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
unc-51 like kinase 4 | 0.722 | 0.385 | 4.4E-38 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
inflammation and lipid regulator with UBA-like and NBR1-like domains | 0.705 | 0.385 | 0.85 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
regulatory factor X7 | 0.780 | 0.385 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
downregulated RNA in cancer, inhibitor of cell invasion and migration | 0.736 | 0.423 |
|
disease | 0.100 | None | 1.000 | 6 | 3 | 2008 | 2017 | |||||||||
|
cancer susceptibility 19 | 0.769 | 0.423 |
|
disease | 0.100 | None | 1.000 | 3 | 3 | 2013 | 2017 | |||||||||
|
myoneurin | 0.722 | 0.423 | 0.57 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
Bcl2 modifying factor | 0.663 | 0.423 | 6.8E-03 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
gametogenetin binding protein 1 (pseudogene) | 0.769 | 0.462 | 0.69 |
|
disease | 0.100 | None | 1.000 | 4 | 2 | 2012 | 2017 | ||||||||
|
vacuole membrane protein 1 | 0.674 | 0.462 | 0.96 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
SP110 nuclear body protein | 0.656 | 0.500 | 1.5E-14 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 |